Bod Australia is set to release a new cannabigerol (CBG) product, which will be sold under the MediCabilis brand. This will be distributed to various medical facilities within the UK.
Medicinal cannabis company Australian Natural Therapeutics Group (ANTG) is set to partner with NUBU Pharmaceuticals, one of New Zealand’s largest medicinal cannabis distributors.
Epsilon Healthcare Limited (ASX:EPN) has installed new equipment at its facility in Southport, Queensland, which is one of the biggest pharmaceutical manufacturing facilities for cannabis worldwide.
Byron Bay-based company ANTG has already sent shipments of medicinal cannabis to Europe, but soon the Australian Natural Therapeutics Group would like to export to the New Zealand market.
A UK cannabis and hemp focused company, Voyager Life Limited, plans to list on the Access section of the Aquis Stock Exchange this year. It comes after a crowdfunding campaign which they started back in February, managed to raise £874,000.
The Elixinol Global Ltd (ASX: EXL) has noted its share prices are increasing by up to 5.88% (to 18 cents per share) after the cannabis and hemp company released its quarterly activity update.
Little Green Pharma (LGP) cannabis company, based in Western Australia has signed a deal with Danish-based company Balancial, to supply CBD oil and cannabis flower products.
A joint delivered right to your door with your takeaway food? That’s exactly what Uber wants to do after legislation at the federal level. But it seems it may not be that easy, and if it does happen, will likely take some time.
As the legalisation and decimalisation of cannabis is slowly being seen in Australia, and around the world, more cannabis companies are appearing on the market. This post looks at some Aussie companies and their latest plans.
The Israeli cannabis producer Seach Medical Group, which already supplies some strains to Australian company Cannatrek, has signed a new deal to import two tonnes of medical cannabis into Australia by the end of 2022.
ECS Botanics has just dispatched its first commercial shipment of medicinal cannabis from their large medicinal cannabis facility in north-western Victoria. The shipment will supply both locals and overseas consumers.
The Australian Natural Therapeutics Group (ANTG) already has their medicinal cannabis crop growing close to Byron Bay, near Armidale. Now they are looking to move its headquarters to the popular beach town.
From the 3rd of May 2021, financial management executive Mr Alan Dworkin will fill his new role as Chief Financial Officer of the cannabis company Bod Australia.
Australian cannabis company Little Green Pharma is noticing a huge rise in people requesting medicinal cannabis medications. Investors have high hopes for shares as the demand for medical cannabis products keeps increasing.
The company MediPharm Labs has sent its first shipment of medical cannabis to Germany, from their facility in Wonthaggi, Victoria. The shipment contained capsules with cannabis oil inside.
A report, issued by FreshLeaf Analytics predicts the Australian cannabis industry will double by the end of next year. However if the industry is to generate more profits, it will need to make medical cannabis medications more accessible.
A cannabis company based in the town of Wonthaggi, in Victoria, has shipped its largest ever shipment of cannabis to Germany. The medications will help to treat patients suffering from cancer related symptoms, and chronic pain.
LeafCann is a botanical extracts company, who has recently opened a new warehouse in South Australia. The warehouse will house medical cannabis products and be as a distribution hub for overseas products.
Cannabis flower medicines are turning out to be popular with Australian doctors, due to its fast pain controlling abilities. The new flower range from Little Green Pharma is a Schedule 8 medicine, which will be prescribed by a doctor.
Australian cannabis company Cronos (ASX: CAU) will be set to start stacking Asian shelves with a pure cannabidiol (CBD) heat and cooling gel for elite athletes to help with recovery. The gels for Australian’s, however, may take some time.
So far, there has not been much in the way of merger & acquisition (MA) within the Australia cannabis industry. With more cannabis companies emerging within Australia, this could soon be about to change.
Taking advantage of the huge, and ever-growing cannabis medical market, CSIRO is looking to partner with local manufacturers to produce medical cannabis products, such as tablets and cough lollies.
Bod Australia (ASX: BDA) have partnered with H&H and have now released numerous medicinal hemp and cannabis products across global the market. This article looks at some of their products and the growing positive outlook.
Despite challenges throughout COVID-19, such as fast moving regulatory change, varying public-health rules and the general worry for the economy, cannabis retailers say the pandemic has had some positive benefits.
Epsilon Healthcare’s (EPN) Telehealth medical cannabis clinic group Tetra Health has opened its first physical clinic in Victoria, Australia. Tetra will be the preferred medical cannabis supplier and partner for in-house consultations.
Western-Australian based cannabis company Little Green Pharma (LGP) has been announced to be the primary supplier of cannabis oils for a national trial for medicinal cannabis in France.
Hemp Farms Australia, one of the country’s largest suppliers of industrial hemp, says that general views around the plant are slowly changing. With its health and medical benefits coming to light, the industry is gradually changing.
Since the start of the COVID-19 pandemic, the market for cannabis-infused products has slowed. But with light at the end of the tunnel, this could be a great time for more cannabis companies to enter the market.
Australian Primary Hemp company has sealed a deal with the supermarket chain Woolworths, which will now be stocking hemp-based baking products in its stores, such as hemp protein bars. CEO Neale Joseph is “really pleased about it’.
Tasmanian Alkaloids’ have opened up a new medicinal cannabis facility in the central-north region of Tasmania. It will cultivate, extract, and create medical cannabis medications, with up to 90 tonnes each year.
